Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Why Vertex Pharmaceuticals Stock Was Soaring Today
09:19pm, Friday, 05'th Aug 2022 The Motley Fool
The company's popular Trikafta continues to boost the fundamentals.
Where Vertex Pharmaceuticals Stands With Analysts
06:15pm, Friday, 05'th Aug 2022 Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
3
2
0
0
Stock Market Takes Bullish Jobs Report In Stride; Vertex Pharmaceuticals Finds Support After Earnings
05:21pm, Friday, 05'th Aug 2022
The stock market fell sharply early Friday on news of strong job growth in July, but indexes pared losses by the close. The post Stock Market Takes Bullish Jobs Report In Stride; Vertex Pharmaceutical
Why Vertex Pharmaceuticals Stock Was Soaring Today
05:19pm, Friday, 05'th Aug 2022
The company's popular Trikafta continues to boost the fundamentals.
Vertex (VRTX) Beats on Q2 Earnings, Ups 2022 Sales Guidance
01:33pm, Friday, 05'th Aug 2022 Zacks Investment Research
Vertex Pharmaceuticals' (VRTX) Q2 earnings and sales beat estimates. The company increases its revenue guidance for 2022.
Vertex (VRTX) Beats on Q2 Earnings, Ups 2022 Sales Guidance
11:17am, Friday, 05'th Aug 2022
Vertex Pharmaceuticals' (VRTX) Q2 earnings and sales beat estimates. The company increases its revenue guidance for 2022.
Vertex Pharmaceuticals (VRTX) Q2 2022 Earnings Call Transcript
09:30am, Friday, 05'th Aug 2022 The Motley Fool
VRTX earnings call for the period ending June 30, 2022.
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
09:35pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Vertex (VRTX) delivered earnings and revenue surprises of 3.45% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Vertex Pharmaceuticals, Inc. (VRTX) CEO Reshma Kewalramani on Q2 2022 Results - Earnings Call Transcript
08:35pm, Thursday, 04'th Aug 2022
Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Charles Wagner - EVP & CFO Reshma Kewalramani - CEO, President & Director St
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates
06:48pm, Thursday, 04'th Aug 2022
Vertex (VRTX) delivered earnings and revenue surprises of 3.45% and 3.02%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Drug, Biotech Stocks' Q2 Earnings on Aug 4: LLY, AMGN & More
01:48pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Let us look at four large drug and biotech companies, AMGN, VRTX, LLY, NVO, which are gearing up for their earnings release.
With An Economic Recession Looming, Is An Earnings Recession To Follow?
03:06pm, Monday, 01'st Aug 2022 Investing.com
Will Clovis Oncology (CLVS) Report Negative Earnings Next Week? What You Should Know
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
Clovis (CLVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Watch These Leaders With Earnings Due, Buy Zones In Focus
01:11pm, Monday, 01'st Aug 2022
With earnings due, IBD Leaderboard stocks like Eli Lilly, Vertex and Ollie's test bases, breakouts and buy zones. The post Watch These Leaders With Earnings Due, Buy Zones In Focus appeared first on I
Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.2% Jump Turn into More Strength?
12:41pm, Monday, 01'st Aug 2022 Zacks Investment Research
Sarepta Therapeutics (SRPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near
